Chinese biopharma firm IMPACT closes $55m Series D+ round to advance cancer drugs
The Series D+ round was led by GTJA Investment Group and Beijing-based state capital investor Kingray Capital.
Source: dealstreetasia.com
Kingray Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kingray Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Kingray Capital Today - Breaking & Trending Today
Chinese biopharmaceutical firm Atom Bioscience snaps over $82m in Series D round
Biopharmaceutical firm Jiangsu Atom Bioscience and Pharmaceutical has bagged 600 million yuan ($82.8 million) in a Series D funding round.
Source: dealstreetasia.com
DAS Solar bags funding and 48 more updates from Greater China worth about $853m
Previously, the Quzhou-headquartered firm secured an undisclosed sum in February, joined by China Renaissance, and CICC Capital, among others.
Source: dealstreetasia.com
Chinese advanced polymer materials maker TopOlefin snags $139m in Series B round
TopOlefin Technology has raked in 1 billion yuan ($138.9 million) in a Series B round led by local PE investment firms Kingray Capital and Raystone Capital.
Source: dealstreetasia.com
Chinese biotech firm Trinomab closes $104m pre-IPO round to advance product pipeline
The round was led by PE investment firm Kingray Capital and Gree Financial Investment.
Source: dealstreetasia.com